Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish oil-based intravenous lipid emulsions for parenteral nutrition-associated hypertriglyceridemia
2018-002715-10Phase 2Active
- Sponsor
- Bellvitge University Hospital
- Start
- Nov 2018
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid and Clinoleic in hypertriglyceridemia (3 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Temporal variation of plasma triglycerides. Started Nov 2018; status: active.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acidClinoleic
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on 2018-002715-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002715-10.